LUDG on OTC
LUDWIG ENTERPRISES, INC.
American medical laboratories services company, incorporated in Nevada. Summary from the record
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with Aclarion, Inc., SERA PROGNOSTICS, INC. or Advanced Biomed Inc., or pick any stock.
- TickerLUDG on OTC1
- IndustryServices-Medical Laboratories1
- HeadquartersPompano Beach, Florida1
- Incorporated inNV2
- Business address3160 Nw 1 Avenue, Pompano Beach, Fl 330642
- Filer category, Emerging growth company2
See how the biggest companies compare on our leaderboards
50–74 report having had a mammogram within the prior two years, yet breast cancer continues to be the most commonly diagnosed cancer.3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2024
Where the money goes
Where each dollar of revenue went, fiscal 2024
- Research and development100¢$165.6K
Out of $217 in revenue.4 The company lost money this year.
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenues | $217 | |
| General and administration expenses | $1.5M | $1.1M |
| Research and development | $231.6K | $165.6K |
| Total operating expenses | $1.8M | $1.3M |
| Net loss from operations | -$1.8M | -$1.3M |
| Interest income | $6.0K | |
| Other income | $2.3K | |
| Inducement expense | -$1.0M | |
| Finance expense | -$677.1K | |
| Interest expense | -$91.9K | -$56.8K |
| Loss on debt extinguishment | -$117.2K | |
| Gain on Change in fair value of derivative liability | $535.3K | |
| Amortization of debt discount | -$796.3K | -$15.0K |
| Total other expense | -$461.8K | -$1.8M |
| Net loss before taxes | -$2.2M | -$3.1M |
| Loss from continuing operations | -$2.2M | -$3.1M |
| Income from discontinued operation, net of tax | $34.8K | |
| Net loss | -$2.2M | -$3.0M |
| Basic loss per common share from continuing operations (in Dollars per share) | -$0 | -$0 |
| Diluted loss per common share from continuing operation (in Dollars per share) | -$0 | -$0 |
| Basic income per common share from discontinued operations (in Dollars per share) | $0 | $0 |
| Diluted income per common share from discontinued operations (in Dollars per share) | $0 | $0 |
| Basic loss per common share (in Dollars per share) | -$0.01 | -$0.02 |
| Diluted loss per common share (in Dollars per share) | -$0.01 | -$0.02 |
| Basic weighted average common shares outstanding (in Shares) | 161.8M shares | 158.6M shares |
| Diluted weighted average common shares outstanding (in Shares) | 161.8M shares | 158.6M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash | $6.7K | $108.3K | |
| Inventory | $4.5K | $3.0K | |
| Prepaid expenses | $14.9K | $27.8K | |
| Deferred offering cost | $113.0K | $60.0K | |
| Note receivable | $106.0K | $100.0K | |
| Total Current Assets | $238.4K | $197.6K | |
| Intangible assets, net of accumulated | $9.2K | ||
| Total Assets | $247.5K | $197.6K | |
| Bank overdraft | $1.3K | ||
| Accounts payable and accrued expenses | $791.4K | $353.1K | |
| Accounts payable and accrued expenses related party | $811.4K | $268.9K | |
| Notes payable | $1.3M | $1.4M | |
| Convertible notes payable, net | $1.2M | $578.7K | |
| Derivative liability | $535.5K | ||
| Total Current Liabilities | $4.6M | $2.6M | |
| Total Liabilities | $4.6M | $2.6M | |
| Preferred stock: 7,000,000 authorized; $0.001 par value, 7,000,000 shares issued and outstanding at December 31, 2025 and 2024 | $7.0K | $7.0K | |
| Common stock: 1,250,000,000 authorized; $0.001 par value, 162,569,807 and 160,512,807 shares issued and outstanding at December 31, 2025 and 2024 | $162.6K | $160.5K | |
| Additional paid in capital | $4.9M | $4.7M | |
| Accumulated deficit | -$9.5M | -$7.3M | |
| Total Stockholders Deficit | -$4.4M | -$2.4M | -$1.5M |
| Total Liabilities and Stockholders Deficit | $247.5K | $197.6K | |
| Preferred stock, authorized (in Shares) | 7.0M shares | 7.0M shares | |
| Preferred stock, par value (in Dollars per share) | $0.00 | $0.00 | |
| Preferred stock, shares issued (in Shares) | 7.0M shares | 7.0M shares | |
| Preferred stock, shares outstanding (in Shares) | 7.0M shares | 7.0M shares | |
| Common stock authorized (in Shares) | 1.2B shares | 1.2B shares | |
| Common stock par value (in Dollars per share) | $0.00 | $0.00 | |
| Common stock, shares issued (in Shares) | 162.6M shares | 160.5M shares | |
| Common stock, shares outstanding (in Shares) | 162.6M shares | 160.5M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash | $6.7K | $108.3K | |
| Inventory | $4.5K | $3.0K | |
| Prepaid expenses | $14.9K | $27.8K | |
| Deferred offering cost | $113.0K | $60.0K | |
| Note receivable | $106.0K | $100.0K | |
| Total Current Assets | $238.4K | $197.6K | |
| Intangible assets, net of accumulated | $9.2K | ||
| Total Assets | $247.5K | $197.6K | |
| Bank overdraft | $1.3K | ||
| Accounts payable and accrued expenses | $791.4K | $353.1K | |
| Accounts payable and accrued expenses related party | $811.4K | $268.9K | |
| Notes payable | $1.3M | $1.4M | |
| Convertible notes payable, net | $1.2M | $578.7K | |
| Derivative liability | $535.5K | ||
| Total Current Liabilities | $4.6M | $2.6M | |
| Total Liabilities | $4.6M | $2.6M | |
| Preferred stock: 7,000,000 authorized; $0.001 par value, 7,000,000 shares issued and outstanding at December 31, 2025 and 2024 | $7.0K | $7.0K | |
| Common stock: 1,250,000,000 authorized; $0.001 par value, 162,569,807 and 160,512,807 shares issued and outstanding at December 31, 2025 and 2024 | $162.6K | $160.5K | |
| Additional paid in capital | $4.9M | $4.7M | |
| Accumulated deficit | -$9.5M | -$7.3M | |
| Total Stockholders Deficit | -$4.4M | -$2.4M | -$1.5M |
| Total Liabilities and Stockholders Deficit | $247.5K | $197.6K | |
| Preferred stock, authorized (in Shares) | 7.0M shares | 7.0M shares | |
| Preferred stock, par value (in Dollars per share) | $0.00 | $0.00 | |
| Preferred stock, shares issued (in Shares) | 7.0M shares | 7.0M shares | |
| Preferred stock, shares outstanding (in Shares) | 7.0M shares | 7.0M shares | |
| Common stock authorized (in Shares) | 1.2B shares | 1.2B shares | |
| Common stock par value (in Dollars per share) | $0.00 | $0.00 | |
| Common stock, shares issued (in Shares) | 162.6M shares | 160.5M shares | |
| Common stock, shares outstanding (in Shares) | 162.6M shares | 160.5M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss | -$2.2M | -$3.0M |
| Stock issued for services | $226.4K | $317.8K |
| Stock issued for research and development | $100.8K | |
| Stocks issued for inducements | $1.0M | |
| Stock warrants issued for finance cost | $677.1K | |
| Gain on sale of subsidiary | -$203.3K | |
| Amortization of debt discount | $796.3K | $15.0K |
| Loss on extinguishment of debt | $117.2K | |
| Change in fair value of derivative liability | -$535.3K | |
| Inventory | -$1.5K | -$3.0K |
| Note Receivable | -$6.0K | |
| Prepaid expenses | $12.9K | -$23.6K |
| Unearned fee | -$50.0K | |
| Accounts payable and accrued liabilities | $464.7K | $316.2K |
| Accounts payable and accrued liabilities related party | $516.9K | $205.1K |
| Net Cash Used in Operating Activities | -$644.8K | -$660.3K |
| Purchase of intellectual property | -$9.2K | |
| Net Cash Used in Investing Activities | -$9.2K | |
| Deferred offering cost | -$53.0K | -$60.0K |
| Proceeds from related party | $61.0K | $5.0K |
| Repayments to related party | -$12.1K | |
| Proceeds from convertible notes payable - net | $750.0K | $618.7K |
| Repayment of convertible note and guaranteed interest | -$55.0K | |
| Repayment of note payable | -$100.0K | |
| Cash advance from investor | $50.0K | |
| Increase in bank overdraft | $1.3K | |
| Net Cash Provided by Financing Activities | $647.3K | $558.7K |
| Net change in cash | -$6.7K | -$101.6K |
| Cash paid for interest | $12.8K | $5.0K |
| Original issuance debt and guaranteed interest as debt discount | $15.0K | |
| Derivative liability recognized as debt discount | $953.6K | |
| Note receivable acquired in exchange with sale of subsidiary | $100.0K | |
| Derivative liability recognized in connection with extinguishment of debt | $117.2K |
No quarter-by-quarter statement was filed.
Leadership
Who has led LUDWIG ENTERPRISES, INC., and when. Pick a name to see everywhere that person has worked.
Chief executive
- Chief executive officerCharles T. Todd Jr. May 20, 2025 to now10
Board members and other officers (2)
- Board memberCharles T. Todd Jr. May 20, 2025 to now10
- Board memberGarth Lees-Rolfe Jun 26, 2025 to now11
Timeline
- May 20, 2025New chief executive Charles T. Todd Jr. becomes CEO10
Filings
73 filings to the SEC since October 2021: 3 annual reports, 8 quarterly reports, 17 major events, 3 insider forms, 42 other. The latest 20:
- Oct 6, 20268-K CURRENT REPORT ON FORM 8-K EDGAR
- Aug 14, 2026NT 10-Q FORM 12B-25 - NOTIFICATION OF LATE FILING EDGAR
- May 29, 202610-Q QUARTERLY REPORT EDGAR
- May 15, 2026NT 10-Q NOTIFICATION OF LATE FILING EDGAR
- May 1, 20264 PRIMARY DOCUMENT EDGAR
- Apr 2, 2026S-1/A AMENDMENT NO. 3 TO FORM S-1 EDGAR
- Mar 16, 202610-K ANNUAL REPORT EDGAR
- Feb 12, 2026S-1/A AMENDMENT NO. 2 TO FORM S-1 EDGAR
- Feb 11, 20268-K CURRENT REPORT EDGAR
- Nov 12, 202510-Q QUARTERLY REPORT EDGAR
- Oct 14, 2025S-1/A AMENDMENT NO. 1 TO FORM S-1 EDGAR
- Oct 1, 20258-K CURRENT REPORT EDGAR
- Sep 8, 20258-K CURRENT REPORT EDGAR
- Aug 12, 202510-Q QUARTERLY REPORT EDGAR
- Jul 30, 20258-K CURRENT REPORT EDGAR
- Jul 15, 2025DEF 14C INFORMATION STATEMENT EDGAR
- Jun 27, 2025PRE 14C PRELIMINARY INFORMATION STATEMENT EDGAR
- Jun 26, 20253 EDGAR
- Jun 25, 20258-K CURRENT REPORT EDGAR
- Jun 6, 20258-K CURRENT REPORT EDGAR
The 73 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
2 open-market trades by officers, directors and large owners since October 2021: 0 buys and 2 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Apr 29, 2026 | HAUSMAN MARVIN S MD10% owner | Sale | 500,000 | $0.02 | $10.0K | Form 4 |
| Apr 20, 2026 | HAUSMAN MARVIN S MD10% owner | Sale | 1,500,000 | $0.02 | $30.0K | Form 4 |
From Forms 4 filed with the SEC.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11SEC EDGARGarth Lees-Rolfe, Board member